Vorsitz/Chair: Rüdiger Braun-Dullaeus (Magdeburg), Ilka Ott (Pforzheim)
Agenda
(P1623)
Intensive lipid – lowering therapy is highly cost effective in patients with ST – elevation myocardial infarction: a two – year follow – up of “Jena auf Ziel”
Calcimimetika verbessern direkt die durch Phosphat eingeschränkte Herzfunktion und Kardiomyozytenkontraktilität in Mäusen mit eingeschränkter Nierenfunktion
Patient knowledge and management of major risk factors of HbA1c, blood pressure and LDL-C in coronary artery disease patients with and without diabetes mellitus: Results from the KNOW-ABC study
Comparison of LDL-C target achievement and Lp(a) assessment in patients with atherosclerotic cardiovascular disease in differing treatment specialties in Germany: Rationale and design of LipidSnapshot